Literature DB >> 32856712

Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased?

Saki Takahashi1, Bryan Greenhouse1,2, Isabel Rodríguez-Barraquer1.   

Abstract

Biased seroprevalence estimates can occur using serological assays optimized with validation sets unrepresentative of disease spectrum in the general population. Correct interpretation of serosurveys for severe acute respiratory syndrome coronavirus 2 requires quantifying variations in sensitivity with disease severity and over time.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS-CoV-2 seroprevalence; antibody testing; spectrum bias; test performance

Mesh：

Substances：

Year:  2020        PMID： 32856712      PMCID： PMC7499591          DOI： 10.1093/infdis/jiaa523

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  36 in total

1.  Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland.

Authors:  Lindsay McDonald; Helen Wise; Frauke Muecksch; Daniel Poston; Sally Mavin; Kate Templeton; Elizabeth Furrie; Claire Richardson; Jaqueline McGuire; Lisa Jarvis; Kristen Malloy; Andrew McAuley; Norah Palmateer; Elizabeth Dickson; Theodora Hatziioannou; Paul Bieniasz; Sara Jenks
Journal:  J Clin Virol Plus       Date:  2021-06-14

2.  Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 20201.

Authors:  Kirsten E Wiens; Pinyi Nyimol Mawien; John Rumunu; Damien Slater; Forrest K Jones; Serina Moheed; Andrea Caflisch; Bior K Bior; Iboyi Amanya Jacob; Richard Lino Lako; Argata Guracha Guyo; Olushayo Oluseun Olu; Sylvester Maleghemi; Andrew Baguma; Juma John Hassen; Sheila K Baya; Lul Deng; Justin Lessler; Maya N Demby; Vanessa Sanchez; Rachel Mills; Clare Fraser; Richelle C Charles; Jason B Harris; Andrew S Azman; Joseph F Wamala
Journal:  Emerg Infect Dis       Date:  2021-06       Impact factor: 6.883

3.  Seroprevalence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya.

Authors:  Anthony O Etyang; Ruth Lucinde; Henry Karanja; Catherine Kalu; Daisy Mugo; James Nyagwange; John Gitonga; James Tuju; Perpetual Wanjiku; Angela Karani; Shadrack Mutua; Hosea Maroko; Eddy Nzomo; Eric Maitha; Evanson Kamuri; Thuranira Kaugiria; Justus Weru; Lucy B Ochola; Nelson Kilimo; Sande Charo; Namdala Emukule; Wycliffe Moracha; David Mukabi; Rosemary Okuku; Monicah Ogutu; Barrack Angujo; Mark Otiende; Christian Bottomley; Edward Otieno; Leonard Ndwiga; Amek Nyaguara; Shirine Voller; Charles N Agoti; David James Nokes; Lynette Isabella Ochola-Oyier; Rashid Aman; Patrick Amoth; Mercy Mwangangi; Kadondi Kasera; Wangari Ng'ang'a; Ifedayo M O Adetifa; E Wangeci Kagucia; Katherine Gallagher; Sophie Uyoga; Benjamin Tsofa; Edwine Barasa; Philip Bejon; J Anthony G Scott; Ambrose Agweyu; George M Warimwe
Journal:  Clin Infect Dis       Date:  2022-01-29       Impact factor: 9.079

4.  Impact of reduction of susceptibility to SARS-CoV-2 on epidemic dynamics in four early-seeded metropolitan regions.

Authors:  Thomas J Barrett; Karen C Patterson; Timothy M James; Peter Krüger
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

5.  Incorporating false negative tests in epidemiological models for SARS-CoV-2 transmission and reconciling with seroprevalence estimates.

Authors:  Rupam Bhattacharyya; Ritoban Kundu; Ritwik Bhaduri; Debashree Ray; Lauren J Beesley; Maxwell Salvatore; Bhramar Mukherjee
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

6.  Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.

Authors:  Hassan Alkharaan; Shaghayegh Bayati; Cecilia Hellström; Soo Aleman; Annika Olsson; Karin Lindahl; Gordana Bogdanovic; Katie Healy; Georgios Tsilingaridis; Patricia De Palma; Sophia Hober; Anna Månberg; Peter Nilsson; Elisa Pin; Margaret Sällberg Chen
Journal:  J Infect Dis       Date:  2021-08-02       Impact factor: 7.759

7.  Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.

Authors:  Jefferson M Jones; Mars Stone; Hasan Sulaeman; Rebecca V Fink; Honey Dave; Matthew E Levy; Clara Di Germanio; Valerie Green; Edward Notari; Paula Saa; Brad J Biggerstaff; Donna Strauss; Debra Kessler; Ralph Vassallo; Rita Reik; Susan Rossmann; Mark Destree; Kim-Anh Nguyen; Merlyn Sayers; Chris Lough; Daniel W Bougie; Megan Ritter; Gerardo Latoni; Billy Weales; Stacy Sime; Jed Gorlin; Nicole E Brown; Carolyn V Gould; Kevin Berney; Tina J Benoit; Maureen J Miller; Dane Freeman; Deeksha Kartik; Alicia M Fry; Eduardo Azziz-Baumgartner; Aron J Hall; Adam MacNeil; Adi V Gundlapalli; Sridhar V Basavaraju; Susan I Gerber; Monica E Patton; Brian Custer; Phillip Williamson; Graham Simmons; Natalie J Thornburg; Steven Kleinman; Susan L Stramer; Jean Opsomer; Michael P Busch
Journal:  JAMA       Date:  2021-10-12       Impact factor: 56.272

8.  Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay.

Authors:  Sophia Hober; Cecilia Hellström; Jennie Olofsson; Eni Andersson; Sofia Bergström; August Jernbom Falk; Shaghayegh Bayati; Sara Mravinacova; Ronald Sjöberg; Jamil Yousef; Lovisa Skoglund; Sara Kanje; Anna Berling; Anne-Sophie Svensson; Gabriella Jensen; Henric Enstedt; Delaram Afshari; Lan Lan Xu; Martin Zwahlen; Kalle von Feilitzen; Leo Hanke; Ben Murrell; Gerald McInerney; Gunilla B Karlsson Hedestam; Christofer Lendel; Robert G Roth; Ingmar Skoog; Elisabet Svenungsson; Tomas Olsson; Anna Fogdell-Hahn; Ylva Lindroth; Maria Lundgren; Kimia T Maleki; Nina Lagerqvist; Jonas Klingström; Rui Da Silva Rodrigues; Sandra Muschiol; Gordana Bogdanovic; Laila Sara Arroyo Mühr; Carina Eklund; Camilla Lagheden; Joakim Dillner; Åsa Sivertsson; Sebastian Havervall; Charlotte Thålin; Hanna Tegel; Elisa Pin; Anna Månberg; My Hedhammar; Peter Nilsson
Journal:  Clin Transl Immunology       Date:  2021-07-19

9.  AuNP Coupled Rapid Flow-Through Dot-Blot Immuno-Assay for Enhanced Detection of SARS-CoV-2 Specific Nucleocapsid and Receptor Binding Domain IgG.

Authors:  Bijon Kumar Sil; Mohd Raeed Jamiruddin; Md Ahsanul Haq; Mohib Ullah Khondoker; Nowshin Jahan; Shahad Saif Khandker; Tamanna Ali; Mumtarin Jannat Oishee; Taku Kaitsuka; Masayasu Mie; Kazuhito Tomizawa; Eiry Kobatake; Mainul Haque; Nihad Adnan
Journal:  Int J Nanomedicine       Date:  2021-07-09

10.  The early detection of immunoglobulins via optical-based lateral flow immunoassay platform in COVID-19 pandemic.

Authors:  Pang-Yen Chen; Cheng-Hao Ko; C Jason Wang; Chien-Wei Chen; Wei-Huai Chiu; Chitsung Hong; Hao-Min Cheng; I-Jen Wang
Journal:  PLoS One       Date:  2021-07-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.